Literature DB >> 25891442

Resistant Hypertension: A Real Entity or a Phantom Diagnosis?

Costas Thomopoulos1, George Skalis1, Thomas Makris1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25891442      PMCID： PMC8031818          DOI： 10.1111/jch.12565

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  16 in total

1.  Resistant hypertension: do all definitions describe the same patients?

Authors:  L Boswell; J Pascual; A Oliveras
Journal:  J Hum Hypertens       Date:  2015-01-15       Impact factor: 3.012

2.  Guanethidine-resistant hypertension.

Authors:  G Sandler; A W Leishman; P M Humberstone
Journal:  Circulation       Date:  1968-09       Impact factor: 29.690

3.  Use of minoxidil in resistant hypertension. Beneficial effects, adverse reactions and indications.

Authors:  D Hall; F Charocopos; K L Froer; W Rudolph
Journal:  Herz       Date:  1978-10       Impact factor: 1.443

4.  Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries.

Authors:  Clara K Chow; Koon K Teo; Sumathy Rangarajan; Shofiqul Islam; Rajeev Gupta; Alvaro Avezum; Ahmad Bahonar; Jephat Chifamba; Gilles Dagenais; Rafael Diaz; Khawar Kazmi; Fernando Lanas; Li Wei; Patricio Lopez-Jaramillo; Lu Fanghong; Noor Hassim Ismail; Thandi Puoane; Annika Rosengren; Andrzej Szuba; Ahmet Temizhan; Andy Wielgosz; Rita Yusuf; Afzalhussein Yusufali; Martin McKee; Lisheng Liu; Prem Mony; Salim Yusuf
Journal:  JAMA       Date:  2013-09-04       Impact factor: 56.272

5.  A clinical trial of guanoxan (Envacar) in hypertension resistant to common drugs.

Authors:  G Persson; B Ekwall; C Fürst
Journal:  Acta Med Scand       Date:  1967-11

6.  First report of the Global SYMPLICITY Registry on the effect of renal artery denervation in patients with uncontrolled hypertension.

Authors:  Michael Böhm; Felix Mahfoud; Christian Ukena; Uta C Hoppe; Krzysztof Narkiewicz; Manuela Negoita; Luis Ruilope; Markus P Schlaich; Roland E Schmieder; Robert Whitbourn; Bryan Williams; Uwe Zeymer; Andreas Zirlik; Giuseppe Mancia
Journal:  Hypertension       Date:  2015-02-17       Impact factor: 10.190

7.  Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.

Authors:  David A Calhoun; Daniel Jones; Stephen Textor; David C Goff; Timothy P Murphy; Robert D Toto; Anthony White; William C Cushman; William White; Domenic Sica; Keith Ferdinand; Thomas D Giles; Bonita Falkner; Robert M Carey
Journal:  Circulation       Date:  2008-06-24       Impact factor: 29.690

8.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

9.  A role of frusemide in resistant hypertension.

Authors:  M Wilson; T Morgan; A Gillies
Journal:  Med J Aust       Date:  1977-02-12       Impact factor: 7.738

10.  Dynamic resistant hypertension patterns as predictors of cardiovascular morbidity: a 4-year prospective study.

Authors:  Costas Tsioufis; Alexandros Kasiakogias; Athanasios Kordalis; Kyriakos Dimitriadis; Costas Thomopoulos; Dimitrios Tsiachris; Panagiotis Vasileiou; Michalis Doumas; Thomas Makris; Vasilios Papademetriou; Ioannis Kallikazaros; George Bakris; Christodoulos Stefanadis
Journal:  J Hypertens       Date:  2014-02       Impact factor: 4.844
View more
  3 in total

Review 1.  Resistant Hypertension: A Real Entity Requiring Special Treatment?

Authors:  Stefano Taddei; Rosa Maria Bruno
Journal:  Eur Cardiol       Date:  2016-08

2.  Cystatin C, vascular biomarkers and measured glomerular filtration rate in patients with unresponsive hypertensive phenotype: a pilot study.

Authors:  Velibor Čabarkapa; Branislava Ilinčić; Mirjana Đerić; Viktorija Vučaj Ćirilović; Milena Kresoja; Radmila Žeravica; Vladimir Sakač
Journal:  Ren Fail       Date:  2016-11-23       Impact factor: 2.606

Review 3.  Pharmacogenomics of amlodipine and hydrochlorothiazide therapy and the quest for improved control of hypertension: a mini review.

Authors:  Rabia Johnson; Phiwayinkosi Dludla; Sihle Mabhida; Mongi Benjeddou; Johan Louw; Faghri February
Journal:  Heart Fail Rev       Date:  2019-05       Impact factor: 4.214
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.